Related Experiment Videos
Evidence that polyoma polypeptide VP1 is a serine protease
Virology
|June 1, 1984
Summary
Polyoma virus (Py) virions release new polypeptides through proteolysis of VP1. This process is inhibited by serine protease inhibitors, indicating VP1
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Polyoma virus (Py) virions are composed of structural proteins, including VP1.
- Understanding virion protein processing is crucial for viral replication studies.
Purpose of the Study:
- To investigate the mechanism of polyoma virion polypeptide processing.
- To identify the enzyme responsible for proteolysis of VP1.
Main Methods:
- Dissociation of purified Py virions under specific buffer conditions (150 mM NaCl, 50 mM Tris-HCl pH 8.5, 1 mM EGTA, 3 mM DTT).
- Inhibition studies using serine protease inhibitors diisopropyl fluorophosphonate (DFP) and phenylmethyl sulfonyl fluoride (PMSF).
- Radiolabeling experiments with DFP to identify the protease activity site.
Main Results:
- Incubation of Py virions resulted in the production of two new polypeptides (43.5K and 40K) from VP1 proteolysis.
- Proteolysis was blocked by DFP and PMSF, suggesting a serine protease involvement.
- Radiolabeled DFP preferentially labeled VP1, indicating protease activity resides within VP1.
Conclusions:
- The virion-associated protease activity is a property of polyoma virus VP1.
- The 43.5K and 40K polypeptides are generated through VP1 autodigestion.
- Polyoma virus VP1 possesses intrinsic serine protease activity responsible for its own processing.